US Stock MarketDetailed Quotes

NVS Novartis AG

Watchlist
  • 107.220
  • -4.580-4.10%
Close Jul 18 16:00 ET
  • 106.900
  • -0.320-0.30%
Pre 05:07 ET
217.08BMarket Cap13.75P/E (TTM)

Novartis AG Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
38.61%4.88B
-20.58%2.27B
9.06%14.22B
-32.40%2.55B
24.07%5.3B
-5.58%3.52B
72.95%2.85B
-2.44%13.04B
73.00%3.77B
-13.20%4.28B
Net income from continuing operations
42.93%3.25B
25.02%2.69B
41.71%8.57B
100.61%2.64B
13.76%1.51B
33.98%2.27B
-3.11%2.15B
-73.59%6.05B
-91.34%1.32B
-51.78%1.33B
Operating gains losses
-15.91%74M
132.89%99M
43.77%-167M
186.29%107M
-520.00%-62M
161.11%88M
-296.05%-301M
98.14%-297M
99.15%-124M
96.88%-10M
Depreciation and amortization
-31.97%1.16B
-29.73%1.31B
23.45%8.28B
-12.84%1.59B
62.45%3.11B
-5.22%1.71B
33.10%1.87B
19.80%6.71B
81.66%1.82B
31.80%1.92B
Deferred tax
47.64%595M
19.19%441M
-51.15%551M
-202.76%-261M
-84.82%39M
16.14%403M
-17.78%370M
-30.58%1.13B
68.21%254M
-45.55%257M
Other non cash items
-71.54%-223M
65.18%-180M
-26,066.67%-785M
53.23%-87M
-134.01%-50M
-402.33%-130M
-10,240.00%-517M
98.56%-3M
-745.45%-186M
88.46%147M
Change In working capital
332.73%238M
-63.30%-1.99B
53.64%-369M
-184.21%-384M
163.53%1.18B
201.85%55M
39.43%-1.22B
-990.41%-796M
-47.10%456M
9.29%447M
-Change in receivables
-12.08%-501M
-31.43%-920M
-278.84%-1.5B
-156.07%-240M
13.97%-117M
-8.23%-447M
-41.13%-700M
-12.78%-397M
100.94%428M
20.47%-136M
-Change in inventory
90.27%-18M
64.54%-128M
2.50%-546M
171.74%33M
74.42%-33M
4.64%-185M
15.06%-361M
-449.02%-560M
-155.56%-46M
-231.63%-129M
-Change in payables and accrued expense
-294.52%-142M
-1,673.08%-409M
364.64%479M
291.67%564M
-52.07%-184M
563.64%73M
118.18%26M
-63.06%-181M
-68.83%144M
-23.47%-121M
-Change in other current assets
-1,266.67%-105M
-149.54%-272M
-48.81%-125M
-2,150.00%-41M
-87.40%16M
-87.14%9M
69.97%-109M
53.07%-84M
-99.27%2M
301.59%127M
-Change in other current liabilities
65.95%1B
-251.35%-260M
211.50%1.33B
-872.22%-700M
111.90%1.5B
28.18%605M
87.33%-74M
-36.51%426M
-4.35%-72M
9.80%706M
Cash from discontinued investing activities
-80.12%238M
0
-83.41%74M
59M
105M
-29.84%1.2B
343M
446M
Operating cash flow
36.33%4.88B
-23.40%2.27B
1.56%14.46B
-38.04%2.55B
13.92%5.38B
-4.77%3.58B
79.32%2.96B
-5.54%14.24B
5.84%4.11B
-4.14%4.72B
Investing cash flow
Cash flow from continuing investing activities
-234.06%-3.21B
-108.40%-899M
252.89%6.72B
22.52%-1.02B
-137.75%-2B
91.74%-960M
14.31%10.71B
-61.12%1.9B
-125.11%-1.32B
528.84%5.31B
Net PPE purchase and sale
-0.90%-223M
-50.67%-226M
-8.58%-823M
-18.63%-242M
-4.48%-210M
9.43%-221M
33.04%-150M
11.35%-758M
-98.06%-204M
25.56%-201M
Net intangibles purchase and sale
33.43%-448M
-920.88%-929M
122.72%262M
-95.31%-375M
664.92%1.4B
-238.19%-673M
83.02%-91M
-43.41%-1.15B
51.02%-192M
-62.09%-248M
Net business purchase and sale
-3,773.26%-3.33B
-911.54%-263M
-313.08%-3.57B
-22.22%-11M
-57,533.33%-3.45B
-40.98%-86M
96.90%-26M
-104.22%-864M
-100.04%-9M
135.29%6M
Net investment purchase and sale
3,875.00%795M
-95.27%519M
131.82%10.85B
56.89%-394M
-95.64%251M
100.18%20M
0.07%10.97B
133.78%4.68B
93.88%-914M
832.87%5.75B
Net other investing changes
----
----
----
----
----
----
----
98.18%-1M
--0
92.31%-1M
Cash from discontinued investing activities
Investing cash flow
-204.56%-3.21B
-108.46%-899M
281.20%5.6B
-19.97%-1.76B
-142.55%-2.21B
90.94%-1.05B
13.41%10.62B
-65.11%1.47B
-132.15%-1.47B
521.92%5.2B
Financing cash flow
Cash flow from continuing financing activities
15.03%-3.2B
42.60%-5.16B
15.07%-17.56B
87.90%-496M
9.33%-4.31B
-63.60%-3.77B
5.58%-9B
-26.96%-20.68B
-25.08%-4.1B
-206.78%-4.75B
Net issuance payments of debt
207.62%833M
23.58%1.15B
25.15%-1.94B
148.41%610M
-31.07%-2.7B
-333.84%-774M
130.94%933M
56.82%-2.59B
59.50%-1.26B
-63.73%-2.06B
Net common stock issuance
45.35%-1.62B
61.92%-1.1B
18.15%-8.72B
53.29%-1.25B
40.21%-1.63B
-8.95%-2.96B
-13.53%-2.89B
-248.45%-10.65B
-1,709.46%-2.68B
-857.04%-2.72B
Cash dividends paid
---2.42B
28.23%-5.21B
3.34%-7.26B
--0
----
----
3.34%-7.26B
-1.87%-7.51B
--0
----
Proceeds from stock option exercised by employees
--25M
----
53.00%153M
---5M
---1M
----
69.15%159M
88.68%100M
--0
----
Net other financing activities
28.57%-25M
-120.75%-11M
605.26%192M
193.17%150M
-25.00%24M
-146.67%-35M
140.91%53M
-155.07%-38M
-794.44%-161M
900.00%32M
Cash from discontinued financing activities
2,661.34%3.29B
-205.71%-111M
31,481.82%3.47B
129M
-206M
357.69%119M
105M
-21.43%11M
Financing cash flow
12.02%-3.2B
43.88%-5.16B
30.56%-14.28B
84.80%-607M
82.44%-832M
-57.99%-3.64B
3.42%-9.2B
-26.43%-20.56B
-22.85%-3.99B
-208.87%-4.74B
Net cash flow
Beginning cash position
-21.09%9.47B
78.17%13.39B
-39.41%7.52B
42.16%12.41B
200.28%10.89B
-13.37%12B
-39.41%7.52B
28.46%12.41B
21.01%8.73B
-29.16%3.63B
Current changes in cash
-37.52%-1.53B
-186.79%-3.8B
218.90%5.78B
161.33%828M
-67.46%1.69B
89.05%-1.11B
194.48%4.38B
-261.13%-4.86B
-125.98%-1.35B
139.97%5.18B
Effect of exchange rate changes
-3,300.00%-34M
-217.76%-126M
412.50%100M
13.48%160M
-107.50%-166M
98.08%-1M
360.98%107M
87.97%-32M
--141M
-23.08%-80M
End cash Position
-27.40%7.9B
-21.09%9.47B
78.17%13.39B
78.17%13.39B
42.16%12.41B
200.28%10.89B
-13.37%12B
-39.41%7.52B
-39.41%7.52B
21.01%8.73B
Free cash flow
54.85%4.15B
-56.81%1.11B
-2.43%11.71B
-51.18%1.76B
10.50%4.7B
-15.57%2.68B
225.06%2.57B
-4.14%12B
8.76%3.61B
-3.12%4.25B
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 38.61%4.88B-20.58%2.27B9.06%14.22B-32.40%2.55B24.07%5.3B-5.58%3.52B72.95%2.85B-2.44%13.04B73.00%3.77B-13.20%4.28B
Net income from continuing operations 42.93%3.25B25.02%2.69B41.71%8.57B100.61%2.64B13.76%1.51B33.98%2.27B-3.11%2.15B-73.59%6.05B-91.34%1.32B-51.78%1.33B
Operating gains losses -15.91%74M132.89%99M43.77%-167M186.29%107M-520.00%-62M161.11%88M-296.05%-301M98.14%-297M99.15%-124M96.88%-10M
Depreciation and amortization -31.97%1.16B-29.73%1.31B23.45%8.28B-12.84%1.59B62.45%3.11B-5.22%1.71B33.10%1.87B19.80%6.71B81.66%1.82B31.80%1.92B
Deferred tax 47.64%595M19.19%441M-51.15%551M-202.76%-261M-84.82%39M16.14%403M-17.78%370M-30.58%1.13B68.21%254M-45.55%257M
Other non cash items -71.54%-223M65.18%-180M-26,066.67%-785M53.23%-87M-134.01%-50M-402.33%-130M-10,240.00%-517M98.56%-3M-745.45%-186M88.46%147M
Change In working capital 332.73%238M-63.30%-1.99B53.64%-369M-184.21%-384M163.53%1.18B201.85%55M39.43%-1.22B-990.41%-796M-47.10%456M9.29%447M
-Change in receivables -12.08%-501M-31.43%-920M-278.84%-1.5B-156.07%-240M13.97%-117M-8.23%-447M-41.13%-700M-12.78%-397M100.94%428M20.47%-136M
-Change in inventory 90.27%-18M64.54%-128M2.50%-546M171.74%33M74.42%-33M4.64%-185M15.06%-361M-449.02%-560M-155.56%-46M-231.63%-129M
-Change in payables and accrued expense -294.52%-142M-1,673.08%-409M364.64%479M291.67%564M-52.07%-184M563.64%73M118.18%26M-63.06%-181M-68.83%144M-23.47%-121M
-Change in other current assets -1,266.67%-105M-149.54%-272M-48.81%-125M-2,150.00%-41M-87.40%16M-87.14%9M69.97%-109M53.07%-84M-99.27%2M301.59%127M
-Change in other current liabilities 65.95%1B-251.35%-260M211.50%1.33B-872.22%-700M111.90%1.5B28.18%605M87.33%-74M-36.51%426M-4.35%-72M9.80%706M
Cash from discontinued investing activities -80.12%238M0-83.41%74M59M105M-29.84%1.2B343M446M
Operating cash flow 36.33%4.88B-23.40%2.27B1.56%14.46B-38.04%2.55B13.92%5.38B-4.77%3.58B79.32%2.96B-5.54%14.24B5.84%4.11B-4.14%4.72B
Investing cash flow
Cash flow from continuing investing activities -234.06%-3.21B-108.40%-899M252.89%6.72B22.52%-1.02B-137.75%-2B91.74%-960M14.31%10.71B-61.12%1.9B-125.11%-1.32B528.84%5.31B
Net PPE purchase and sale -0.90%-223M-50.67%-226M-8.58%-823M-18.63%-242M-4.48%-210M9.43%-221M33.04%-150M11.35%-758M-98.06%-204M25.56%-201M
Net intangibles purchase and sale 33.43%-448M-920.88%-929M122.72%262M-95.31%-375M664.92%1.4B-238.19%-673M83.02%-91M-43.41%-1.15B51.02%-192M-62.09%-248M
Net business purchase and sale -3,773.26%-3.33B-911.54%-263M-313.08%-3.57B-22.22%-11M-57,533.33%-3.45B-40.98%-86M96.90%-26M-104.22%-864M-100.04%-9M135.29%6M
Net investment purchase and sale 3,875.00%795M-95.27%519M131.82%10.85B56.89%-394M-95.64%251M100.18%20M0.07%10.97B133.78%4.68B93.88%-914M832.87%5.75B
Net other investing changes ----------------------------98.18%-1M--092.31%-1M
Cash from discontinued investing activities
Investing cash flow -204.56%-3.21B-108.46%-899M281.20%5.6B-19.97%-1.76B-142.55%-2.21B90.94%-1.05B13.41%10.62B-65.11%1.47B-132.15%-1.47B521.92%5.2B
Financing cash flow
Cash flow from continuing financing activities 15.03%-3.2B42.60%-5.16B15.07%-17.56B87.90%-496M9.33%-4.31B-63.60%-3.77B5.58%-9B-26.96%-20.68B-25.08%-4.1B-206.78%-4.75B
Net issuance payments of debt 207.62%833M23.58%1.15B25.15%-1.94B148.41%610M-31.07%-2.7B-333.84%-774M130.94%933M56.82%-2.59B59.50%-1.26B-63.73%-2.06B
Net common stock issuance 45.35%-1.62B61.92%-1.1B18.15%-8.72B53.29%-1.25B40.21%-1.63B-8.95%-2.96B-13.53%-2.89B-248.45%-10.65B-1,709.46%-2.68B-857.04%-2.72B
Cash dividends paid ---2.42B28.23%-5.21B3.34%-7.26B--0--------3.34%-7.26B-1.87%-7.51B--0----
Proceeds from stock option exercised by employees --25M----53.00%153M---5M---1M----69.15%159M88.68%100M--0----
Net other financing activities 28.57%-25M-120.75%-11M605.26%192M193.17%150M-25.00%24M-146.67%-35M140.91%53M-155.07%-38M-794.44%-161M900.00%32M
Cash from discontinued financing activities 2,661.34%3.29B-205.71%-111M31,481.82%3.47B129M-206M357.69%119M105M-21.43%11M
Financing cash flow 12.02%-3.2B43.88%-5.16B30.56%-14.28B84.80%-607M82.44%-832M-57.99%-3.64B3.42%-9.2B-26.43%-20.56B-22.85%-3.99B-208.87%-4.74B
Net cash flow
Beginning cash position -21.09%9.47B78.17%13.39B-39.41%7.52B42.16%12.41B200.28%10.89B-13.37%12B-39.41%7.52B28.46%12.41B21.01%8.73B-29.16%3.63B
Current changes in cash -37.52%-1.53B-186.79%-3.8B218.90%5.78B161.33%828M-67.46%1.69B89.05%-1.11B194.48%4.38B-261.13%-4.86B-125.98%-1.35B139.97%5.18B
Effect of exchange rate changes -3,300.00%-34M-217.76%-126M412.50%100M13.48%160M-107.50%-166M98.08%-1M360.98%107M87.97%-32M--141M-23.08%-80M
End cash Position -27.40%7.9B-21.09%9.47B78.17%13.39B78.17%13.39B42.16%12.41B200.28%10.89B-13.37%12B-39.41%7.52B-39.41%7.52B21.01%8.73B
Free cash flow 54.85%4.15B-56.81%1.11B-2.43%11.71B-51.18%1.76B10.50%4.7B-15.57%2.68B225.06%2.57B-4.14%12B8.76%3.61B-3.12%4.25B
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ----Unqualified Opinion--------Unqualified Opinion----

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg
Concept CAR-T Therapy
CAR-T Therapy
Intraday-1.51%
Cancer Research
Cancer Research
Intraday-1.84%